80 FR 49252 - Notice of Kidney Interagency Coordinating Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 158 (August 17, 2015)

Page Range		49252-49252
FR Document		2015-20219

The Kidney Interagency Coordinating Committee (KICC) will hold a meeting on September 25, 2015, on the pharmacist's role in chronic kidney disease care. The meeting is open to the public.

Federal Register, Volume 80 Issue 158 (Monday, August 17, 2015)

[Federal Register Volume 80, Number 158 (Monday, August 17, 2015)]
[Notices]
[Page 49252]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-20219]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Kidney Interagency Coordinating Committee Meeting

SUMMARY: The Kidney Interagency Coordinating Committee (KICC) will hold 
a meeting on September 25, 2015, on the pharmacist's role in chronic 
kidney disease care. The meeting is open to the public.

DATES: The meeting will be held on September 25, 2015, 9 a.m. to 12 
p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the Natcher Conference Center on 
the NIH Campus at 9000 Rockville Pike, Bethesda, MD 20894.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the 
Kidney Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A27, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594-
8864; FAX: 301-480-0243; email: [email protected].

SUPPLEMENTARY INFORMATION: The KICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK), comprises 
members of the Department of Health and Human Services and other 
federal agencies that support kidney-related activities, facilitates 
cooperation, communication, and collaboration on kidney disease among 
government entities. KICC meetings, held twice a year, provide an 
opportunity for Committee members to learn about and discuss current 
and future kidney programs in KICC member organizations and to identify 
opportunities for collaboration. The September 25, 2015 KICC meeting 
will focus on the pharmacist's role in chronic kidney disease care.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future KICC meetings should send a request to 
[email protected].

    Dated: August 4, 2015.
Camille M. Hoover,
Executive Officer, National Institute of Diabetes and Digestive and 
Kidney Diseases, National Institutes of Health.
[FR Doc. 2015-20219 Filed 8-14-15; 8:45 am]
 BILLING CODE 4140-01-P

49252 Federal Register / Vol. 80, No. 158 / Monday, August 17, 2015 / Notices

DEPARTMENT OF HEALTH AND DATES: The meeting will be held on meeting, oral comments will be allowed
HUMAN SERVICES September 25, 2015, 9 a.m. to 12 p.m. on a first-come, first-serve basis.
Individuals wanting to present oral Members of the public who would
National Institutes of Health comments must notify the contact like to receive email notification about
person at least 10 days before the future KICC meetings should send a
National Institute of Allergy and meeting date.
Infectious Diseases; Notice of Closed request to nkdep@info.niddk.nih.gov.
ADDRESSES: The meeting will be held in Dated: August 4, 2015.
Meeting
the Natcher Conference Center on the Camille M. Hoover,
Pursuant to section 10(d) of the NIH Campus at 9000 Rockville Pike,
Executive Officer, National Institute of
Federal Advisory Committee Act, as Bethesda, MD 20894. Diabetes and Digestive and Kidney Diseases,
amended (5 U.S.C. App.), notice is FOR FURTHER INFORMATION CONTACT: For National Institutes of Health.
hereby given of the following meeting. further information concerning this [FR Doc. 2015–20219 Filed 8–14–15; 8:45 am]
The meeting will be closed to the meeting, contact Dr. Andrew S. Narva, BILLING CODE 4140–01–P
public in accordance with the Executive Secretary of the Kidney
provisions set forth in sections Interagency Coordinating Committee,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institute of Diabetes and DEPARTMENT OF HEALTH AND
as amended. The grant applications and Digestive and Kidney Diseases, 31 HUMAN SERVICES
the discussions could disclose Center Drive, Building 31A, Room
confidential trade secrets or commercial 9A27, MSC 2560, Bethesda, MD 20892– National Institutes of Health
property such as patentable material, 2560, telephone: 301–594–8864; FAX:
and personal information concerning 301–480–0243; email: nkdep@ Center for Scientific Review; Notice of
individuals associated with the grant info.niddk.nih.gov. Closed Meetings
applications, the disclosure of which
would constitute a clearly unwarranted SUPPLEMENTARY INFORMATION: The KICC, Pursuant to section 10(d) of the
invasion of personal privacy. chaired by the National Institute of Federal Advisory Committee Act, as
Diabetes and Digestive and Kidney amended (5 U.S.C. App.), notice is
Name of Committee: National Institute of
Allergy and Infectious Diseases Special Diseases (NIDDK), comprises members hereby given of the following meetings.
Emphasis Panel; NIAID Investigator Initiated of the Department of Health and Human
The meetings will be closed to the
Program Project Applications (P01). Services and other federal agencies that
public in accordance with the
Date: September 10, 2015. support kidney-related activities,
provisions set forth in sections
Time: 12:30 p.m. to 3:30 p.m. facilitates cooperation, communication,
Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
and collaboration on kidney disease
applications. as amended. The grant applications and
among government entities. KICC
Place: National Institutes of Health Room the discussions could disclose
meetings, held twice a year, provide an
3F100, 5601 Fishers Lane, Rockville, MD confidential trade secrets or commercial
opportunity for Committee members to
20892 (Telephone Conference Call). property such as patentable material,
Contact Person: Louis A. Rosenthal, Ph.D., learn about and discuss current and
and personal information concerning
Scientific Review Officer, Scientific Review future kidney programs in KICC member
individuals associated with the grant
Program, Division of Extramural Activities, organizations and to identify
applications, the disclosure of which
Rm 3G42B, National Institutes of Health/ opportunities for collaboration. The
would constitute a clearly unwarranted
NIAID, 5601 Fishers Lane, MSC–79823, September 25, 2015 KICC meeting will
Bethesda, MD 20892–9823, (240) 669–5070,
invasion of personal privacy.
focus on the pharmacist’s role in
rosenthalla@niaid.nih.gov. chronic kidney disease care. Name of Committee: Center for Scientific
(Catalogue of Federal Domestic Assistance Review Special Emphasis Panel, Predoctoral
Any member of the public interested
Program Nos. 93.855, Allergy, Immunology, Training Programs in Big Data Science.
in presenting oral comments to the Date: September 24, 2015.
and Transplantation Research; 93.856,
Committee should notify the contact Time: 10:00 a.m. to 6:00 p.m.
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS) person listed on this notice at least 10 Agenda: To review and evaluate grant
days in advance of the meeting. applications.
Dated: August 12, 2015. Interested individuals and Place: National Institutes of Health, 6701
Melanie J. Gray, representatives or organizations should Rockledge Drive, Bethesda, MD 20892.
Program Analyst, Office of Federal Advisory submit a letter of intent, a brief Contact Person: Feng Tao, Ph.D., Scientific
Committee Policy. description of the organization Review Officer, Center for Scientific Review,
[FR Doc. 2015–20211 Filed 8–14–15; 8:45 am] represented, and a written copy of their National Institutes of Health, 6701 Rockledge
Drive Room 6184, MSC 7849, Bethesda, MD
BILLING CODE 4140–01–P oral presentation in advance of the 20892, (301) 451–3940, feng.tao@nih.gov.
meeting. Only one representative of an
Name of Committee: Molecular, Cellular
organization will be allowed to present; and Developmental Neuroscience Integrated
DEPARTMENT OF HEALTH AND oral comments and presentations will be Review Group, Neurotransporters, Receptors,
HUMAN SERVICES limited to a maximum of 5 minutes. and Calcium Signaling Study Section.
Printed and electronic copies are Date: September 28–29, 2015.
National Institutes of Health requested for the record. In addition, Time: 8:00 a.m. to 1:00 p.m.
any interested person may file written Agenda: To review and evaluate grant
Notice of Kidney Interagency applications.
mstockstill on DSK4VPTVN1PROD with NOTICES

Coordinating Committee Meeting comments with the Committee by
forwarding their statement to the Place: Hotel Monaco, 700 F Street NW.,
contact person listed on this notice. The Washington, DC 20001.
SUMMARY: The Kidney Interagency
Contact Person: Peter B Guthrie, Ph.D.,
Coordinating Committee (KICC) will statement should include the name, Scientific Review Officer, Center for
hold a meeting on September 25, 2015, address, telephone number and when Scientific Review, National Institutes of
on the pharmacist’s role in chronic applicable, the business or professional Health, 6701 Rockledge Drive, Room 4182,
kidney disease care. The meeting is affiliation of the interested person. MSC 7850, Bethesda, MD 20892, (301) 435–
open to the public. Because of time constraints for the 1239, guthriep@csr.nih.gov.

VerDate Sep<11>2014 16:57 Aug 14, 2015 Jkt 235001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\17AUN1.SGM 17AUN1

Document Created: 2015-12-15 11:07:00
Document Modified: 2015-12-15 11:07:00

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		The meeting will be held on September 25, 2015, 9 a.m. to 12 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date.
Contact		For further information concerning this meeting, contact Dr. Andrew S. Narva, Executive Secretary of the Kidney Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A27, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-594- 8864; FAX: 301-480-0243; email: [email protected]
FR Citation		80 FR 49252

80 FR 49252 - Notice of Kidney Interagency Coordinating Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 158 (August 17, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health